September 10, 2026 - 05:31

Construction of the PennSTART facility near New Stanton is moving forward, with operations expected to begin in 2027. The site will feature a dedicated test track designed to support the development of autonomous vehicles and advanced transportation technologies.
The project aims to give companies, researchers, and public agencies a controlled environment where they can evaluate new systems before those systems reach public roads. Testing areas will allow for a range of scenarios, from basic vehicle handling to complex interactions between sensors, software, and infrastructure.
Supporters say the facility could strengthen the region's position in the growing mobility sector. By providing space for hands-on experimentation, PennSTART may attract startups, established firms, and academic teams that need realistic conditions without the risks of open traffic.
Work on the site continues as planners finalize details for the track layout and supporting buildings. Once complete, the facility is expected to host year round testing and serve as a hub for collaboration among industry and research partners. Officials view the 2027 opening as a key step toward keeping Pennsylvania competitive in transportation innovation.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...